A Clinical Research on the Safety/Efficacy of Human Umbilical Cord Mesenchymal Stem Cell (19#iSCLife®-CSD) Therapy for Patients With Healing Poor After Uterus Injury
Latest Information Update: 08 Feb 2022
At a glance
- Drugs Umbilical cord mesenchymal stem cell therapy Sclnow Biotechnology (Primary)
- Indications Uterine diseases; Wounds
- Focus Therapeutic Use
- Sponsors Sclnow Biotechnology
Most Recent Events
- 21 Sep 2021 Phase of the trial is changed from phase 2 to phase 3.
- 21 Sep 2021 Status changed from recruiting to completed.
- 26 Oct 2020 Planned End Date changed from 1 Dec 2020 to 1 Dec 2021.